Sign in
4

Changes in Ownership

NOVAVAX INC Filed Acc 0001209191-21-058570

President, R&D sold 693 shares at an average $207.25 ($143,622)

From the SEC's structured data for this filing

Trades in this filing

Glenn Gregory M · President, R&D

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-30 Sale : show line 1 in the form −51 $202.84 $10,345 4,703 D
2021-09-30 Sale : show line 2 in the form −55 $203.94 $11,217 4,648 D
2021-09-30 Sale : show line 3 in the form −16 $205.01 $3,280 4,632 D
2021-09-30 Sale : show line 4 in the form −280 $207.01 $57,962 4,352 D
2021-09-30 Sale : show line 5 in the form −117 $207.99 $24,335 4,235 D
2021-09-30 Sale : show line 6 in the form −118 $209.27 $24,694 4,117 D
2021-09-30 Sale : show line 7 in the form −40 $210.16 $8,406 4,077 D
2021-09-30 Sale : show line 8 in the form −16 $211.39 $3,382 4,061 D
Open-market sales · 693 sh · avg $207.25 · $143,622
Loading xslF345X03/doc4.xml…